Cargando…
Membrane-interactive lipids as experimental anticancer drugs.
Autor principal: | Berdel, W. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977494/ https://www.ncbi.nlm.nih.gov/pubmed/1892746 |
Ejemplares similares
-
The interaction of supramolecular anticancer drug amphiphiles with phospholipid membranes
por: Tang, Phu K., et al.
Publicado: (2020) -
Defensin–lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics
por: Hein, Matthew J. A., et al.
Publicado: (2022) -
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy
por: Marques, Ana Camila, et al.
Publicado: (2023) -
Licofelone-DPPC Interactions: Putting Membrane Lipids on the Radar of Drug Development
por: Pereira-Leite, Catarina, et al.
Publicado: (2019) -
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023)